Wiley Periodicals, Inc

SHERPA: Unknown

People

  1. Cheung
    Cheung
  2. Modak
    Modak
  3. Kushner
    Kushner
  4. Basu
    Basu
  5. Kramer
    Kramer
  6. Pandit-Taskar
    Pandit-Taskar
  7. Wolden
    Wolden
  8. La Quaglia
    La Quaglia
  9. Carrasquillo
    Carrasquillo
  10. Cheung
    Cheung

Groups

  1. Neuroblastoma Service (119)
  2. Pediatrics, Department of (119)
  3. GSK Faculty (76)
  4. Tow Center for Developmental Oncology (TCDO) (75)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (70)
  6. Center for Hematologic Malignancies (39)
  7. Center for Molecular Imaging and Biotechnology (38)
  8. Neuro-Oncology Service (38)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (37)
  10. Pediatric Leukemia (31)
Search Within
  1. "Neuroblastoma Service"
Formats
  1. Meeting Abstract (67)
  2. Journal Article (48)
  3. Correspondence (2)
  4. Editorial (2)
Groups
  1. Neuroblastoma Service (119)
  2. Pediatrics, Department of (119)
  3. GSK Faculty (76)
  4. Tow Center for Developmental Oncology (TCDO) (75)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (70)
  6. Center for Hematologic Malignancies (39)

More Groups

People
  1. Nai-Kong Cheung (70)
  2. Shakeel Modak (68)
  3. Brian Kushner (65)
  4. Ellen Basu (36)
  5. Stephen Roberts (36)
  6. Kim Kramer (30)

More People

Years
  1. 2024 (1)
  2. 2023 (9)
  3. 2022 (8)
  4. 2021 (11)
  5. 2020 (17)
  6. 2019 (12)

More Years

Publications
  1. Pediatric Blood and Cancer (115)
  2. Genes Chromosomes and Cancer (4)

Results (119)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Clinical impact of ALK mutations in neuroblastoma
    Meeting Abstract

    O'Donohue, T.; Gulati, N.; Shukla, N.; Roberts, S.; Basu, E.; Kushner, B.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Prognostic significance of ATRX aberrations in neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Kushner, B.; Cheung, N. K.; Shukla, N.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Phase 1/2 trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors
    Meeting Abstract

    Desai, A. V.; Gajjar, A.; Gauvain, K.; Basu, E. M.; Macy, M. E.; Maese, L.; Sabnis, A. J.; Foster, J.; Shusterman, S.; Yoon, J.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of "HITS" pilot/phase II study
    Meeting Abstract

    Modak, S.; Kushner, B.; Flores, M.; Santa-Maria, V.; Garraus, M.; Basu, E.; Roberts, S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma
    Journal Article

    Stone, A.; Friedman, D. N.; Kushner, B. H.; Wolden, S.; Modak, S.; LaQuaglia, M. P.; Costello, J.; Wu, X.; Cheung, N. K.; Sklar, C. A.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Intraventricular 131I-labeled monoclonal antibody 8H9 (omburtomab) targeting the surface glycoprotein B7-H3 in patients with CNS malignancies
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2018)

    Fulltext@MSK | Save
  • Feasibility of outpatient stem cell rescue in high risk neuroblastoma patients
    Meeting Abstract

    Glincher, R.; Modak, S.; Basu, E.
    Pediatric Blood and Cancer (2018)

    Fulltext@MSK | Save